SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-036426
Filing Date
2019-06-12
Accepted
2019-06-12 17:00:25
Documents
1
Period of Report
2019-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12088
  Complete submission text file 0001209191-19-036426.txt   13566
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Issuer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ANAPTYSBIO, INC. 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Suria Hamza (Reporting) CIK: 0001654495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37985 | Film No.: 19894158